Palaiseau, France

Joël Raingeaud


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joël Raingeaud: Innovator in Dermatological Treatments

Introduction

Joël Raingeaud is a notable inventor based in Palaiseau, France. He has made significant contributions to the field of dermatology through his innovative research and patenting of isolated peptides derived from fibrinogen. His work focuses on developing treatments for inflammatory skin diseases, particularly acne.

Latest Patents

Raingeaud holds a patent for "Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases." This invention relates to isolated peptides obtained from human fibrinogen, which are intended for use as drugs to prevent and treat inflammatory skin diseases, especially acne. The patent also encompasses fragments of these polypeptides, nucleic acid molecules encoding them, expression vectors, host cells, pharmaceutical compositions, and combination products containing them.

Career Highlights

Throughout his career, Joël Raingeaud has worked with prestigious institutions, including Université Paris Descartes and Assistance Publique-Hôpitaux de Paris. His research has contributed to advancements in the understanding and treatment of skin conditions, showcasing his commitment to improving patient care.

Collaborations

Raingeaud has collaborated with notable professionals in his field, including Nicolas Dupin and Philippe Grange. These partnerships have further enhanced his research and development efforts in dermatological innovations.

Conclusion

Joël Raingeaud's contributions to the field of dermatology through his patented innovations highlight his role as a key inventor in the treatment of skin inflammatory diseases. His work continues to pave the way for new therapeutic options for patients suffering from conditions like acne.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…